Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 11, 2024Clinical ImmunologyOpen Access

The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

WYWei Zhen YehMGMelissa GresleRLRod A. Lea

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yeh et al. (2024) studied this question.

synapsesocial.com/papers/68e74937b6db6435876c19dahttps://doi.org/10.1016/j.clim.2024.110183
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genomic, Epigenomic, and Immuno-Genomic Regulations of Vitamin D Supplementation in Multiple Sclerosis: A Literature Review and in Silico Meta-Analysis2025 · 1 citations
  2. 2Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers2024 · 2 citations
  3. 3Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis2020 · 27 citations
  4. 4VITAMIN D3 IN THE PATHOGENESIS AND CLINICAL COURSE OF MULTIPLE SCLEROSIS: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE (2015–2026)2026
  5. 5In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals2024 · 3 citations